Snk Pharma Limited in Birmingham, B11 1HH

Description

Data updated on: 01-11-2023

Snk Pharma started its operations in the year 2011 as a Private Limited Company under the ID 07760088. This business has operated for 13 years and it's currently active. The company's office is located in Birmingham at 23 Dearman Road. You can also locate the firm by its postal code of B11 1HH. This enterprise's Standard Industrial Classification Code is 86900 and their NACE code stands for Other human health activities. Fri, 30th Sep 2022 is the last time when account status updates were filed.

We have a single director presently running the following limited company, namely Sohail K. who's been executing the director's obligations since 2011-09-02.

Sohail K. is the individual with significant control over this firm, owns over 3/4 of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30
Currency
Net Worth	772	1 266	3 428	5 705	6 284	10 247

Balance Sheet
Cash Bank On Hand						7 224	7 912	4 178	6 885	7 813	4 696
Current Assets	18 581	13 550	12 616	15 618	14 802	18 188	22 587	4 178	6 885	56 747	53 630
Debtors	1 183	2 320	10 552	7 809		10 964	14 675			48 934	48 934
Net Assets Liabilities						10 247	7 990	100	100	100	100
Other Debtors						73				48 934	48 934
Property Plant Equipment						429	214	107	53	26	13
Cash Bank In Hand	17 398	11 230	2 064	7 809
Net Assets Liabilities Including Pension Asset Liability	772	1 266	3 428	7 578	6 249	10 247
Tangible Fixed Assets	590	82	646	200

Capital & Reserves
Called Up Share Capital	100	100	100	100
Profit Loss Account Reserve	672	1 166	3 328	5 605
Shareholder Funds	772	1 266	3 428	5 705	6 284	10 247

Other Financial Data
Version Production Software									2 020		1
Accumulated Depreciation Impairment Property Plant Equipment						3 897	4 112	4 219	4 273	4 300	4 313
Average Number Employees During Period							3	3	2	2	2
Bank Borrowings										50 000
Bank Overdrafts										50 000	45 789
Comprehensive Income Expense										22 413	13 975
Corporation Tax Payable										5 264	3 281
Creditors						8 370	14 811	4 185	6 838	6 673	7 754
Dividends Paid											13 975
Fixed Assets	590	82	646	200	162	429				26	13
Income Expense Recognised Directly In Equity											13 975
Increase From Depreciation Charge For Year Property Plant Equipment							215	107	54	27	13
Net Current Assets Liabilities	182	1 184	2 782	7 324	6 122	9 818	7 776	-7	47	50 074	45 876
Other Creditors						1 662	9 815	1 096	594	1 409
Profit Loss										22 413	13 975
Property Plant Equipment Gross Cost						4 326	4 326	4 326	4 326	4 326	4 326
Taxation Social Security Payable						6 708	4 996	3 089	6 244	5 264
Total Assets Less Current Liabilities	772	1 266	3 428	7 578	6 249	10 247			100	50 100	45 889
Trade Creditors Trade Payables										1 409	4 473
Trade Debtors Trade Receivables						10 891	14 675
Creditors Due Within One Year	18 399	12 366	9 834	10 113	9 002	8 370
Number Shares Allotted	100	100	100	100
Other Debtors Due After One Year	1 183	2 320	10 552	7 809
Par Value Share	1	1	1	1
Secured Debts	18 399	12 366	9 834	10 113	9 002
Share Capital Allotted Called Up Paid	100	100	100	100
Tangible Fixed Assets Additions	1 180	165	1 291	400
Tangible Fixed Assets Cost Or Valuation	1 180	1 345	2 636	3 036
Tangible Fixed Assets Depreciation	590	1 263	1 990	2 836
Tangible Fixed Assets Depreciation Charged In Period	590	673	727	846
Amount Specific Advance Or Credit Directors	10 070	3 309	848	2 051

Company staff

Sohail K.

Role: Director

Appointed: 02 September 2011

Latest update: 23 March 2024

People with significant control

Sohail K.

Notified on 1 July 2016

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	30 June 2024
Account last made up date	30 September 2022
Confirmation statement next due date	29 August 2024
Confirmation statement last made up date	15 August 2023

Annual Accounts 2 June 2013
Start Date For Period Covered By Report	2011-09-02
End Date For Period Covered By Report	2012-09-30
Date Approval Accounts	2 June 2013
Annual Accounts
Start Date For Period Covered By Report	2012-10-01
End Date For Period Covered By Report	2013-09-30
Annual Accounts 29 June 2015
Start Date For Period Covered By Report	2013-10-01
End Date For Period Covered By Report	2014-09-30
Date Approval Accounts	29 June 2015
Annual Accounts 30 June 2016
Start Date For Period Covered By Report	2014-10-01
End Date For Period Covered By Report	2015-09-30
Date Approval Accounts	30 June 2016
Annual Accounts 30 June 2017
Start Date For Period Covered By Report	2015-10-01
End Date For Period Covered By Report	2016-09-30
Date Approval Accounts	30 June 2017
Annual Accounts 28 June 2018
Start Date For Period Covered By Report	2016-10-01
End Date For Period Covered By Report	2017-09-30
Date Approval Accounts	28 June 2018
Annual Accounts
Start Date For Period Covered By Report	1 October 2018
End Date For Period Covered By Report	30 September 2019
Annual Accounts
Start Date For Period Covered By Report	1 October 2019
End Date For Period Covered By Report	30 September 2020
Annual Accounts
Start Date For Period Covered By Report	1 October 2020
End Date For Period Covered By Report	30 September 2021
Annual Accounts
Start Date For Period Covered By Report	2021-10-01
End Date For Period Covered By Report	2022-09-30
Annual Accounts
End Date For Period Covered By Report	30 September 2018
Annual Accounts 9 October 2013
Date Approval Accounts	9 October 2013

Snk Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Sohail K.

People with significant control

Sohail K.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies